Onoe Shunsuke, Yokoyama Yukihiro, Kokuryo Toshio, Igami Tsuyoshi, Mizuno Takashi, Yamaguchi Junpei, Watanabe Nobuyuki, Kawakatsu Shoji, Ebata Tomoki
Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan; Division of Perioperative Medicine, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Surgery. 2021 Jun;169(6):1463-1470. doi: 10.1016/j.surg.2020.11.035. Epub 2021 Jan 8.
Nutritional status and tumor markers are important prognostic indicators for surgical decisions in pancreatic carcinoma. This study aimed to stratify the probability of surviving pancreatic carcinoma based on systematically chosen nonanatomic biomarkers.
We included 187 consecutive patients that underwent surgical resections for pancreatic carcinoma. We performed multivariable analyses to evaluate prognostic indicators, including 4 blood-test indexes: the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, prognostic nutritional index, and the modified Glasgow prognostic score; and 4 body-composition indexes: the normalized total psoas muscle area, the normalized total elector spine muscle area, the psoas muscle computed tomography value, and the elector spine muscle computed tomography value.
Poor survival was associated with 2 independent risk factors: neutrophil-to-lymphocyte ratio ≥3.0 (hazard ratio, 1.54) and prognostic nutritional index <36 (hazard ratio, 1.60), and with high carbohydrate antigen 19-9 levels (≥37 IU/mL). The 2 indexes were not significantly associated with clinicopathological factors, including carbohydrate antigen 19-9. Patients with no risk factors had significantly better survival than those with 1 (P = .007) or 2 risk factors (P = .001), and survival was similar in the latter 2 groups (P = .253). A presurgical nonanatomic scoring system (range, 0-2) was constructed: 0 points for no risk factors, 1 point for 1 or 2 nutritional risk factors, and 1 point for carbohydrate antigen 19-9 ≥37 IU/mL. Survival rate at 3 years decreased with increasing scores (76% for score 0, 42% for score 1, and 21% for score 2; all P < .05).
Neutrophil-to-lymphocyte ratio and prognostic nutritional index were independent prognostic risk factors in pancreatic carcinoma and integrating these indexes with carbohydrate antigen 19-9 levels could successfully stratify survival.
营养状况和肿瘤标志物是胰腺癌手术决策的重要预后指标。本研究旨在基于系统选择的非解剖学生物标志物对胰腺癌的生存概率进行分层。
我们纳入了187例连续接受胰腺癌手术切除的患者。我们进行多变量分析以评估预后指标,包括4项血液检测指标:中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值、预后营养指数和改良格拉斯哥预后评分;以及4项身体成分指标:标准化腰大肌总面积、标准化竖脊肌总面积、腰大肌计算机断层扫描值和竖脊肌计算机断层扫描值。
生存不佳与2个独立危险因素相关:中性粒细胞与淋巴细胞比值≥3.0(风险比,1.54)和预后营养指数<36(风险比,1.60),以及高碳水化合物抗原19-9水平(≥37 IU/mL)。这2项指标与包括碳水化合物抗原19-9在内的临床病理因素无显著相关性。无危险因素的患者生存率显著高于有1个(P = .007)或2个危险因素的患者(P = .001),后两组生存率相似(P = .253)。构建了一个术前非解剖学评分系统(范围为0-2):无危险因素为0分,1个或2个营养危险因素为1分,碳水化合物抗原19-9≥37 IU/mL为1分。3年生存率随评分增加而降低(评分为0时为76%,评分为1时为42%,评分为2时为21%;所有P < .05)。
中性粒细胞与淋巴细胞比值和预后营养指数是胰腺癌独立的预后危险因素,将这些指标与碳水化合物抗原19-9水平相结合可成功对生存进行分层。